Open-source EDA tools are free, readily available, and growing in numbers, but many chipmakers are wary of using them due to ...

James Stavridis, former NATO Chief Admiral, joined the Cats Roundtable radio show Sunday morning to weigh in on the impact of ...

Tennessean music writer Audrey Gibbs drags columnist Brad Schmitt along to watch Aussie cowboys dance around and rip off ...

The Buffalo Bills' quarterback and the NFL confirmed that proper procedure was followed when Josh Allen re-entered the ...

Daniel Aula has found opportunity in Springfield. But he’s also found himself in the middle of a bitter national debate on ...

New statistics from the American Cancer Society show a decline in breast cancer mortality nationwide, but an uptick in ...

Theme parks and the airport in Orlando announced reopenings Friday, but officials warned more flooding could continue in the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Chris Eubank Jr. played down his altercation with Conor Benn ahead of his bout with Kamil Szeremeta at the weigh-in ...

Women won’t like it,’” Trump told supporters in Scranton, Pa., this week. “I said, ‘I don’t care.’” The array of swipes ...

Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as soon as 2024, according to people with knowledge of the matter.

Kalen DeBoer said Alabama football went "down to the wire" with South Carolina. Is this what the Crimson Tide should expect ...